Tag Archives: Pharmaceuticals

Pressemitteilungen

A Market for Omega-3 Products in the Form of Application, Geography and its Inclusivity in Different Food Items

Omega 3 fatty acids belongs to essential polysaturated fatty acids category. Omega 3 fatty acids are extensively found in flaxseed oil, canola oil, halibut, salmon, herring, trout, cod, and spinach, clams, shrimp, and chia seeds, among others. There are three different types of omega 3 fatty acids such as α-linolenic acid (ALA) found in plant sources, eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) are extensively found in fish in high concentrations. Due to its great health benefits such as improving eye health, controlling blood pressure and cholesterol, among others, they are filled in the market and available as oral supplements under various brand names.

Factors such as increase in the prevalence of cardiovascular diseases is the key factor enhancing the growth of the omega 3 ingredients market. Rising health consciousness among the people is the attributing the market growth. Its application in various functional and food supplements is anticipating the growth of the omega 3 ingredients market. Increase in research and development activities are adding scope for the manufacturers in expansion. However, the stringent government regulations are likely to hamper the market growth of the omega 3 ingredients.

The global market of Omega 3 ingredients market is categorized as follows-

1. Application

· Pharmaceuticals

· Pet and Animal Feed

· Supplements and Functional Foods

· Infant formula

· Others

And on basis of geographical regions, the global omega 3 ingredients market is divided into five main regions- North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. North America omega 3 ingredients market is the dominant market when compared with that of the other regional markets. Owing to the presence of various industries such as pharmaceutical industries and food industries, the growth of the omega 3 ingredients is found to have a significant growth in this region. The next in line is Europe region in the global omega 3 ingredients market. The Asia Pacific omega 3 ingredients market is expected to grow exponentially in the near future due to the presence of emerging economies such as China, Japan, and India.

Some of the players in the global omega 3 ingredients market include Simris Alg (Sweden), Algisys (U.S), Polaris (U.S), Terravia (Solazyme) (U.S), Bioceuticals (U.S), DSM Nutritional Products (Netherlands), Bioprocess Algae, LLC (U.S), Neptune Wellness Solutions (Canada), Source-Omega (U.S). Some of the market developments include Nordic Naturals introducing five new children’s products at natural products in 2018. The new products offer concentrated, triglyceride-form omega-3 fish oil in age-appropriate formulations for cognition, learning and attention, mood health, and more, plus a kid-friendly, fast-melt probiotic powder.

For More Information: https://www.precisionbusinessinsights.com/market-reports/omega-3-ingredients-market/

Aktuelle Nachrichten Gesundheit/Medizin Marketing/Werbung Mode/Lifestyle Pressemitteilungen

Global Yeast Extract and Beta Glucan Markt Size, Dynamics, Regional Share, Trends, Competitor Analysis 2013-2017 and Forecast 2018-2024

Global Yeast Extract and Beta Glucan Markt: By Yeast Extract and Beta Glucan Market: By Category (Soluble and Insoleuble), By Source (Cereal, Seaweed, Yeast, and Mushroom), By Application (Bakery & Processed Food, Pharmaceuticals, Beverages, Dairy Products, Animal Feed, and Others) , and Geography – Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2013-2017 and Forecast 2018-2024

 

Global yeast extract and beta glucan market was valued at US $ XX Mn in 2017 and is expected to grow at XX% Compound Annual Growth Rate (CAGR) from 2018 to 2024

 

Market Outline: Yeast Extract and Beta Glucan Market

Yeast extract is generally used in the food as flavorings or additives. They are also used as nutrients for the culture media. Yeast extract is infused with the concentration of yeast cells which are allowed to break and break, which enhances the endogenous digestive enzymes break their proteins into simple compounds. Beta glucans are a group of beta-D-glucose polysaccharides which naturally occurs in the cell walls of bacteria, fungi, and cereals. They are sometimes used as medicine.

 

Market Dynamics: Yeast Extract and Beta Glucan Market

The growth factor of glucan market in various applications is the key factor for the growth of the yeast extract and glucan market. The change in food habits and rising health consciousness among the people is creating the demand for yeast extract and beta glucan. Increase in the application of the yeast extract and beta glucan in pharmaceuticals and food & beverage industry is adding fuel for the growth of the market and providing opportunity for the manufacturers to expand the market offerings. However, the availability of alternative products may hamper the growth of the yeast extract and beta glucan market.

 

Free sample of this report is available upon request @

https://www.precisionbusinessinsights.com/market-reports/yeast-extract-and-beta-glucan-market/#ulp-4H8Z4LpNMLEuOnnx

 

Market Scope: Yeast Extract and Beta Glucan Market

Yeast extract and beta glucan market is segmented based on the category, source and application

Based on the category, the market is segmented into the following:

  • soluble
  • insoluble

Based on the source, the market is segmented into the following:

  • Cereal
  • Seaweed
  • Yeast
  • Mushroom

Based on the application, the market is segmented into the following:

  • Bakery & Processed Food
  • Pharmaceuticals
  • Beverages
  • Dairy Products
  • Animal feed
  • Others

 

Free TOC of this report is available upon request @

https://www.precisionbusinessinsights.com/market-reports/yeast-extract-and-beta-glucan-market/#ulp-c654SbFYO64MsOhu

 

Regional Analysis: Yeast Extract and Beta Glucan Market

Geographically, global yeast extract and beta glucan market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. North America yeast extract and beta glucan market is dominant market when compared with that of other regional markets owing to growing demand from food and pharmaceutical industries. Europe is another region accounted for significant share in the market. Asia Pacific yeast extract and beta glucan market is expected to grow at a significant rate over the forecast period.

 

Ask Analyst for Full Information about this report @

https://www.precisionbusinessinsights.com/market-reports/yeast-extract-and-beta-glucan-market/#ulp-14mlyhjMGhVjZqa3

 

Competition Assessment: Yeast Extract and Beta Glucan Market

Some of the players in the global yeast extract and beta glucan market include:

  • Super Beta Glucan (US)
  • Garuda International (US)
  • Lesaffre Human Care (France)
  • Cargill (US),
  • Kerry Group plc (Israel)
  • Millipore Sigma (US)
  • Tate & Lyle (UK)
  • Royal DSM (Netherlands)
  • Frutarom (Israel)
  • Ohly (Germany)

 

Notable Market Developments: Yeast Extract and Beta Glucan Market

  • In February 2018, Lesaffre acquired Alltech’s yeast extract facility in Serbia.

 

Get access to full summary @

https://www.precisionbusinessinsights.com/market-reports/yeast-extract-and-beta-glucan-market/

 

About Precision Business Insights

Precision Business Insights is one of the leading market research and business consulting firms, which follows a holistic approach to solve the needs of the clients. We adopt and implement proven research methodologies to achieve better results. We help our clients by providing actionable insights and making better decisions. We provide consulting, syndicated and customized market research services based on our client needs.

Contact to Precision Business Insights,

Kemp House,

152 – 160 City Road,

London EC1V 2NX

Email: sales@precisionbusinessinsights.com

Toll Free (US): 1-866-598-1553

Website @ https://www.precisionbusinessinsights.com

Aktuelle Nachrichten Auto/Verkehr Computer/Internet/IT Energie/Natur/Umwelt Essen/Trinken Finanzen/Wirtschaft Gesellschaft/Politik Gesundheit/Medizin Pressemitteilungen Reisen/Tourismus

Global Yeast Extract and Beta Glucan Market – Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2013-2017 and Forecast 2018-2024

Global Yeast Extract and Beta Glucan Market – Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2013-2017 and Forecast 2018-2024

 

Global Yeast Extract and Beta Glucan Market: By Category (Soluble and Insoluble), By Source (Cereal, Seaweed, Yeast, and Mushroom), By Application (Bakery & Processed Food, Pharmaceuticals, Beverages, Dairy Products, Animal Feed, and Others), and Geography – Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2013-2017 and Forecast 2018-2024

 

Global yeast extract and beta glucan market was valued at US$ XX Mn in 2017 and expected to grow at XX% Compound Annual Growth Rate (CAGR) from 2018 to 2024

 

Market Outline: Yeast Extract and Beta Glucan Market

Yeast extract is the generally used in the food as flavorings or additives. They are also used as nutrients for the culture media. Yeast extract is infused with concentration of yeast cell which are allowed to die and breakup, which enhances the endogenous digestive enzymes break their proteins into simpler compounds. Beta glucans are comprised of group of β-D-glucose polysaccharides which occurs naturally in the cell walls of bacteria, fungi, and cereals. They are sometimes used as medicine.

 

Market Dynamics: Yeast Extract and Beta Glucan Market

Increase in the use of yeast extract and beta glucan in various applications is the key factor anticipated to drive the growth of the yeast extract and beta glucan market. The change in food habits and rising health consciousness among the people is creating the demand for yeast extract and beta glucan. Increase in application of the yeast extract and beta glucan in pharmaceuticals and food & beverages industry is adding fuel for the growth of the market and providing opportunity for the manufacturers to expand the market offerings. However, the availability of alternative products may hamper the growth of the yeast extract and beta glucan market.

 

Free sample of this report is available upon request @

https://www.precisionbusinessinsights.com/market-reports/yeast-extract-and-beta-glucan-market/#ulp-4H8Z4LpNMLEuOnnx

 

Market Scope: Yeast Extract and Beta Glucan Market

Yeast extract and beta glucan market is segmented based on the category, source and application

Based on the category, the market is segmented into the following:

  • Soluble
  • Insoluble

Based on the source, the market is segmented into the following:

  • Cereal
  • Seaweed
  • Yeast
  • Mushroom

Based on the application, the market is segmented into the following:

  • Bakery & Processed Food
  • Pharmaceuticals
  • Beverages
  • Dairy Products
  • Animal Feed
  • Others

 

Free TOC of this report is available upon request @

https://www.precisionbusinessinsights.com/market-reports/yeast-extract-and-beta-glucan-market/#ulp-c654SbFYO64MsOhu

 

Regional Analysis:  Yeast Extract and Beta Glucan Market

Geographically, global yeast extract and beta glucan market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. North America yeast extract and beta glucan market is dominant market when compared with that of the other regional markets owing to growing demand from food and pharmaceutical industries. Europe is another region accounted for significant share in the market.  Asia Pacific yeast extract and beta glucan market is expected to grow at significant rate over the forecast period.

 

Ask Analyst for Full Information about this report @

https://www.precisionbusinessinsights.com/market-reports/yeast-extract-and-beta-glucan-market/#ulp-14mlyhjMGhVjZqa3

 

Competition Assessment: Yeast Extract and Beta Glucan Market

Some of the players in the global yeast extract and beta glucan market include:

  • Super Beta Glucan (U.S.)
  • Garuda International (U.S.)
  • Lesaffre Human Care (France)
  • Cargill (U.S.),
  • Kerry Group plc (Israel)
  • MilliporeSigma (U.S.)
  • Tate & Lyle (U.K.)
  • Royal DSM (Netherlands)
  • Frutarom (Israel)
  • Ohly (Germany)

 

Notable Market Developments: Yeast Extract and Beta Glucan Market

  • In February 2018, Lesaffre acquired Alltech’s yeast extract facility in Serbia.

 

Get access to full summary @

https://www.precisionbusinessinsights.com/market-reports/yeast-extract-and-beta-glucan-market/

 

About Precision Business Insights

Precision Business Insights is one of the leading market research and business consulting firm, which follow a holistic approach to solve needs of the clients. We adopt and implement proven research methodologies to achieve better results. We help our clients by providing actionable insights and strategies to make better decisions. We provide consulting, syndicated and customised market research services based on our client needs.

Contact to Precision Business Insights,

Kemp House,

152 – 160 City Road,

London EC1V 2NX

Email: sales@precisionbusinessinsights.com

Toll Free (US):+1-866-598-1553

Website @https://www.precisionbusinessinsights.com

 

 

 

 

Pressemitteilungen

Gene Therapy Market Expected to Reach $4,402 Million, Globally, by 2023

The increase in awareness in regards with the benefits of using gene therapy as compared to conventional therapy for the treatment of various diseases and government support to promote gene therapy related research are the major driving factors that are projected to boost the market growth.

According to a new report published by Allied Market Research, titled, Gene Therapy Market by Vector Type, Gene Type, Application, and Geography: Global Opportunity Analysis and Industry Forecast, 2017-2023,“ the global gene therapy market accounted for $584 million in 2016, and is estimated to reach $4,402 million by 2023, registering a CAGR of 33.3% from 2017 to 2023. North America is the highest contributor in the gene therapy market in 2016; however, Asia-Pacific is expected to witness the highest growth rate during the forecast period.

Request sample PDF brochure at: https://www.alliedmarketresearch.com/request-sample/2841

Gene Therapy Market-AMR
https://www.alliedmarketresearch.com/gene-therapy-market

Gene therapies are promising therapies applicable to a broad range of diseases; their aim is to radically treat the causes of the diseases instead of only relieving the symptoms. They may be effective on a wide range of previously untreated diseases, such as hematological, ocular, neurodegenerative diseases, and several cancers. For example, adeno-associated AAV2 vectors carrying the therapeutic gene (RPE65) intra-retinal injection resulted in improved vision for people with Lebers Congenital Amaurosis. Gene therapies can be applied either in combination with cell products and through an ex vivo treatment mode (e.g. Strimvelis), or directly administered in vitro (e.g. Glybera). Several vectors present clinically relevant options, including adenovirus (AV), adeno-associated virus (AAV), and lentivirus.

The increase in funding for R&D activities pertaining to gene therapy and increase in awareness regarding gene therapy are the major factors that drive the market growth. In addition, increase in government support, ethical acceptance of gene therapy for cancer treatment, and rise in prevalence of cancer can fuel the growth of the gene therapy market. However, high cost associated with the treatment and unwanted immune responses are expected to hamper the market growth.

Among the vector type, viral vectors contribute to the largest share in 2016, and estimated to retain the same trend during the forecast period. Non-viral vector is anticipated to be a lucrative market due to the technological advancement of these vectors with positive results for these therapies during the preclinical and clinical trials for the treatment of various diseases.

Among the gene type, antigen dominates the overall market accounting for two-ninths of the total share in 2016. Among the applications, oncological disorders is the largest contributor towards the market growth.

In 2016, North America accounted for maximum contribution to the total revenue generated, owing to the high prevalence rate of cancer, presence of high disposable income, and high funding for R&D activities associated with gene therapy. However, Asia-Pacific is expected to witness the highest CAGR during the analysis period, attributable to rise in incidence rate of cancer, increase in government initiative to improve healthcare infrastructure, and rise in healthcare expenditure.

Do Purchase inquiry at: https://www.alliedmarketresearch.com/purchase-enquiry/2841

Key Findings of the Gene Therapy Market:

  • Non-viral vectors is projected to grow at the highest rate during the analysis period.
  • Oncological disorders segment generated the highest revenue, and is expected to continue its dominance in future.
  • North America dominated global gene therapy market in 2016, and is projected to continue its dominance in future.
  • China is expected to grow highest in the Asia-Pacific region during the forecast period.
  • Antigen was the largest contributor among the gene type segments.

The key companies profiled in the report include Novartis, Kite Pharma, Inc., GlaxoSmithKline PLC, Spark Therapeutics Inc., Bluebird bio Inc., Genethon, Transgene SA, Applied Genetic Technologies Corporation, Oxford BioMedica, and NewLink Genetics Corp.

Other prominent players in the value chain include Amgen, Epeius Biotechnologies, Abeona Therapeutics, Sanofi, UniQure, Juno Therapeutics, Adaptimmune, Celgene, and Advantagene.

Wissenschaft/Forschung

OTC Pharmaceuticals and Self-medication in Seven Emerging Markets Fastest Growing At CAGR of 10% over the period 2011-2018

„The Report OTC Pharmaceuticals and Self-medication in Seven Emerging Markets – Expanded Access, Aging Populations and Increasing Obesity Levels to Drive Future Growth provides information on pricing, market analysis, shares, forecast, and company profiles for key industry participants. – MarketResearchReports.biz“

GBI Research, the leading business intelligence provider, has released its latest research, OTC Pharmaceuticals and Self-medication in Seven Emerging Markets Expanded Access, Aging Populations and Increasing Obesity Levels to Drive Future Growth, which provides insights into the up-and-coming trends of the Over the Counter (OTC) pharmaceutical market by analyzing the trends in population health, healthcare and self-care in seven emerging markets: China, India, Russia, Brazil, Mexico, Indonesia and Turkey.

View Report At http://www.marketresearchreports.biz/analysis/155687

Six main product categories are covered in the report

  • Cough, cold and allergy treatments

  • Analgesics and antipyretics

  • Gastrointestinal remedies

  • Dermatological products

  • Vitamins, minerals and supplements

  • Lifestyle OTC products

The report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GBI Researchs team of industry experts.

All seven markets are expected to continue growth trends over the period 20112018, with China as the fastest growing market with a CAGR of 10%. Consumers within these markets are increasing in affluence and are becoming more informed in terms of health education matters. This has lead to an increase in self-care and in purchases of OTC pharmaceuticals.

The populations of all seven markets are becoming more elderly as healthcare systems and general living conditions are improving, this is a significant driver for the OTC market as the over 60s use the most OTC products, worldwide, of any age group. Obesity is also increasing within these markets, particularly in China. This will drive the growth of the overall OTC market and will act as a specific driver for weight management products that fall under the lifestyle OTC category.

Download Sample copy of this Report @

http://www.marketresearchreports.biz/sample/sample/155687

Scope

  • The report analyzes trends in population health, healthcare and self-care and uses these trends to inform the future buying habits of the OTC market.

  • Current and future trends of major health issues affecting populations within the markets.

  • Market forecasts for OTC products for each country.

  • OTC market segmentation by six product categories.

  • Information on the local regulatory systems of each country.

Reasons to buy

  • Understand how the OTC market has developed and is continuing to develop within the featured markets.

  • Predict which products are likely to be most successful in the future.

  • Gain an understanding of the possible market available for specific products.

  • Understand how new products can gain OTC status in the featured markets.

Follow us on LinkedIn: https://www.linkedin.com/company/marketresearchreports-biz

Table of Content :

1 Table of Contents

1 Table of Contents 5

1.1 List of Tables 7

1.2 List of Figures 7

2 Introduction 9

3 OTC Pharmaceuticals and Self-medication in Seven Emerging Markets – Overview 10

3.1 Overview 10

3.2 OTC Pharmaceuticals 10

3.3 Rx-to-OTC Switching 10

3.4 Regulation of OTC Pharmaceuticals 11

3.4.1 China 11

3.4.2 India 12

3.4.3 Russia 12

3.4.4 Brazil 13

3.4.5 Mexico 13

3.4.6 Turkey 14

3.4.7 Indonesia 14

4 OTC Pharmaceuticals and Self-medication in Seven Emerging Markets – Product Types 15

4.1 OTC Pharmaceuticals and Self-medication in Seven Emerging Markets – Overview 15

4.2 Leading Product Types 15

4.2.1 Cough, Cold and Allergy 15

4.2.2 Analgesics/Antipyretics 15

4.2.3 Gastrointestinal 16

4.2.4 Dermatologicals 16

4.2.5 Vitamins, Minerals and Supplements 17

4.2.6 Lifestyle OTC Products 17

5 OTC Pharmaceuticals and Self-medication in Seven Emerging Markets – Comparison 18

5.1 OTC Pharmaceuticals and Self-medication in Seven Emerging Markets, 2011-2018 18

5.2 OTC Pharmaceuticals and Self-medication in Seven Emerging Markets – Market Drivers and Restraints 20

5.3 OTC Pharmaceuticals and Self-medication in Seven Emerging Markets, Forecast Methodology 22

6 OTC Pharmaceuticals and Self-medication in Seven Emerging Markets – Geographical Breakdown 23

6.1 China 23

6.1.1 Introduction 23

6.1.2 OTC Category Analysis 30

6.1.3 Key Growth Drivers and Restraints 32

6.1.4 OTC Sales Forecast to 2018 33

6.1.5 Recent Developments 34

6.1.6 Outlook 34

6.2 India 35

6.2.1 Introduction 35

6.2.2 OTC Category Analysis 42

6.2.3 Key Growth Drivers and Restraints 43

6.2.4 OTC Sales Forecast to 2018 44

6.2.5 Recent Developments 45

6.2.6 Outlook 45

6.3 Russia 46

6.3.1 Introduction 46

6.3.2 OTC Category Analysis 52

6.3.3 Key Growth Drivers and Restraints 53

6.3.4 OTC Sales Forecast to 2018 54

6.3.5 Recent Developments 55

6.3.6 Outlook 55

About us

MarketResearchReports.biz is the most comprehensive collection of market research reports. MarketResearchReports.Biz services are specially designed to save time and money for our clients. We are a one stop solution for all your research needs, our main offerings are syndicated research reports, custom research, subscription access and consulting services. We serve all sizes and types of companies spanning across various industries.

Contact us:

State Tower

90 Sate Street, Suite 700

Albany, NY 12207

Tel: +1-518-618-1030

USA: Canada Toll Free: 866-997-4948

Website: http://www.marketresearchreports.biz/

E : sales@marketresearchreports.biz

Gesundheit/Medizin

Europe Spectral Radiation Therapy Equipment Industry 2016 Global Industry Analysis, Market Key Trends, Growth, Shares, Current and Future Players

Europe Spectral Radiation Therapy Equipment Industry 2016 Market Research Report Size and Share Published in 2016-06-13 Available for US$ 3600 at Researchmoz.us

Description

The Europe Spectral Radiation Therapy Equipment Industry 2016 Market Research Report is a professional and in-depth study on the current state of the Spectral Radiation Therapy Equipment industry.

The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The Spectral Radiation Therapy Equipment market analysis is provided for the Europe markets including development trends, competitive landscape analysis, and key regions development status.

Development policies and plans are discussed as well as manufacturing processes and Bill of Materials cost structures are also analyzed. This report also states import/export consumption, supply and demand Figures, cost, price, revenue and gross margins.

The report focuses on Europe major leading industry players providing information such as company profiles, product picture and specification, capacity, production, price, cost, revenue and contact information. Upstream raw materials and equipment and downstream demand analysis is also carried out. The Spectral Radiation Therapy Equipment industry development trends and marketing channels are analyzed. Finally the feasibility of new investment projects are assessed and overall research conclusions offered.

With 156 tables and figures the report provides key statistics on the state of the industry and is a valuable source of guidance and direction for companies and individuals interested in the market.

Get a Sample Copy of the Report: http://www.researchmoz.us/enquiry.php?type=S&repid=734569

Table of Content

1 Industry Overview

1.1 Definition and Specifications of Spectral Radiation Therapy Equipment

1.2 Classification of Spectral Radiation Therapy Equipment

1.3 Applications of Spectral Radiation Therapy Equipment

1.4 Industry Chain Structure of Spectral Radiation Therapy Equipment

1.5 Industry Overview of Spectral Radiation Therapy Equipment

1.6 Industry Policy Analysis of Spectral Radiation Therapy Equipment

1.7 Industry News Analysis of Spectral Radiation Therapy Equipment

2 Manufacturing Cost Structure Analysis of Spectral Radiation Therapy Equipment

2.1 Bill of Materials (BOM) of Spectral Radiation Therapy Equipment

2.2 BOM Price Analysis of Spectral Radiation Therapy Equipment

2.3 Labor Cost Analysis of Spectral Radiation Therapy Equipment

2.4 Depreciation Cost Analysis of Spectral Radiation Therapy Equipment

2.5 Manufacturing Cost Structure Analysis of Spectral Radiation Therapy Equipment

2.6 Manufacturing Process Analysis of Spectral Radiation Therapy Equipment

2.7 Europe Price, Cost and Gross of Spectral Radiation Therapy Equipment 2011-2016

Inquiry on this report: http://www.researchmoz.us/enquiry.php?type=E&repid=734569

3 Technical Data and Manufacturing Plants Analysis

3.1 Capacity and Commercial Production Date of Europe Key Manufacturers in 2015

3.2 Manufacturing Plants Distribution of Europe Key Spectral Radiation Therapy Equipment Manufacturers in 2015

3.3 R&D Status and Technology Source of Europe Spectral Radiation Therapy Equipment Key Manufacturers in 2015

3.4 Raw Materials Sources Analysis of Europe Spectral Radiation Therapy Equipment Key Manufacturers in 2015

4 Production Analysis of Spectral Radiation Therapy Equipment by Regions, Type, and Applications

4.1 Europe Production of Spectral Radiation Therapy Equipment by Regions 2011-2016

4.2 Europe Production of Spectral Radiation Therapy Equipment by Type 2011-2016

4.3 Europe Sales of Spectral Radiation Therapy Equipment by Applications 2011-2016

4.4 Price Analysis of Europe Spectral Radiation Therapy Equipment Key Manufacturers in 2015

4.5 Europe Capacity, Production, Import, Export, Sales, Price, Cost and Revenue of Spectral Radiation Therapy Equipment 2011-2016

Browse All Pharmaceutical Market Research Reports at: http://www.researchmoz.us/pharmaceutical-market-reports-38.html

About ResearchMoz

ResearchMoz is the world’s fastest growing collection of market research reports worldwide. Our database is composed of current market studies from over 100 featured publishers worldwide. Our market research databases integrate statistics with analysis from global, regional, country and company perspectives.

Contact Us:

ResearchMoz
Mr. Nachiket Ghumare, +1-518-621-2074
USA-Canada Toll Free: 866-997-4948
sales@researchmoz.us
http://www.researchmoz.us/

 

 

Gesundheit/Medizin

Respiratory Syncytial Virus (RSV) – Global Industry Analysis, Key Player and Opportunity to 2024

OpportunityAnalyzer: Respiratory Syncytial Virus (RSV) – Opportunity Analysis and Forecasts to 2024 Size and Share Published in 2016-01-01 Available for US$ 10995 at Researchmoz.us

Description

Human respiratory syncytial virus (RSV) is an enveloped, single-stranded, negative-sense ribonucleic acid (RNA) pneumovirus belonging to the family of Paramyxoviridae. The virus was discovered in 1956, first as an isolate from a laboratory chimpanzee displaying symptoms of the common cold, and later from infants suffering from respiratory disease. RSV can cause upper respiratory tract infections (the common cold) and is the most important cause of lower respiratory tract infections, such as bronchiolitis and pneumonia, in infants. RSV is also an important cause of hospitalizations and deaths in elderly adults.

Today, Medimmunes Synagis (palivizumab) is the only licensed intervention for the prevention of RSV in infants at a high risk of severe infection. This humanized, mouse monoclonal antibody (mAb) was first approval in 1998, and while it is an efficacious prophylactic intervention, its short 20-day half-life necessitates monthly dosing during the RSV season. Moreover, the high cost of Synagis limits its use to certain subgroups of infants who are at high risk of severe RSV infection, and it is not indicated for use in elderly adults, leaving a key population of high-risk individuals unprotected. Furthermore, due to the absence of effective RSV-specific antivirals, the treatment of RSV infections is largely restricted to a number of supportive treatment options. GlobalData projects the global RSV marketplace – which, for the purposes of this report, comprises the seven major pharmaceutical markets (7MM; US, France, Germany, Italy, Spain, UK, Japan) – to experience unprecedented growth from 2014-2024, driven by the arrival of novel approaches to prevention and management of RSV.

Highlights

Key Questions Answered

– Based on interviews with key opinion leaders (KOLs), GlobalData has identified the major unmet needs in the RSV marketplace. Will the leading pipeline agents fulfil these unmet needs during the forecast period (2014-2024)?

– What research and development (R&D) strategies will companies leverage to compete in the future RSV marketplace?

– Which patient population(s) are most likely to be targeted by novel RSV prophylactic and therapeutic agents?

– What clinical and commercial factors are likely to influence RSV product uptake in the 7MM?

Key Findings

– The global RSV marketplace – which, for the purposes of this report, encompasses the sales of products for the prevention or treatment of RSV in the 7MM – was worth approximately $640m in 2014. GlobalData projects the market to surpass $2.3bn in sales by 2024, at a compound annual growth rate (CAGR) of 29.9% from 2014-2024. The sales are projected to originate predominantly from the US (a 62% market share), followed distantly by the 5EU (a 29% market share).

– The anticipated arrival of novel prophylactic mAbs that boast improved dosing criteria compared with Synagis, led by MedImmunes MEDI8897, will be a principal driver of RSV market growth across the 7MM. The licensure of the first adult vaccine to offer protection against RSV, Novavaxs RSV-F Vaccine, will also stimulate rapid growth in a previously untapped segment of the marketplace.

– A persistent lack of patient and physician awareness of RSV in adult patients – specifically the infections substantial impact on morbidity and mortality in the elderly – will serve as a key impediment to market growth from 2014-2024.

Get a Sample Copy of the Report: http://www.researchmoz.us/enquiry.php?type=S&repid=699481

Scope

– Overview of RSV infections, including epidemiology, etiology, pathophysiology, symptoms, diagnosis, and current management strategies.

– Topline RSV market revenue from 2014-2024. Annual cost of therapy (ACOT) and major pipeline product sales in this forecast period are included.

– Key topics covered include current treatment options, unmet needs and opportunities, and the drivers and barriers affecting RSV product sales in the 7MM.

– Pipeline analysis: comprehensive data split across different phases, emerging novel trends under development, synopses of innovative early-stage projects, and detailed analysis of late-stage pipeline products.

– Analysis of the current and future market competition in the global RSV market. Insightful review of the key industry drivers, restraints and challenges. Each trend is independently researched to provide qualitative analysis of its implications.

Reasons to buy

The report will enable you to –

– Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies, and by identifying the companies with the most robust pipeline.

– Develop business strategies by understanding the trends shaping and driving the global RSV market.

– Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the RSV market in the future.

– Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of various competitors.

– Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.

– Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments, and strategic partnerships.

Inquiry on this report: http://www.researchmoz.us/enquiry.php?type=E&repid=699481

Table of Content

1 Table of Contents 10

1.1 List of Tables 15

1.2 List of Figures 18

2 Introduction 19

2.1 Catalyst 19

2.2 Related Reports 20

2.3 Upcoming Related Reports 21

3 Disease Overview 22

3.1 Etiology and Pathophysiology 22

3.1.1 Etiology 22

3.1.2 Pathophysiology 26

3.2 Symptoms and Prognosis 28

3.2.1 Symptoms 28

3.2.2 Prognosis 30

3.3 Quality of Life 31

3.4 Disease Management 31

3.4.1 Diagnosis of RSV Infection 32

3.4.2 Prevention of RSV Infection 34

3.4.3 Treatment of RSV Infection 37

4 Epidemiology 40

4.1 Disease Background 40

4.2 Risk Factors and Comorbidities 41

4.3 Global Trends 43

4.3.1 Preterm Infants and Children Born Preterm and Survived to Two Years of Age 44

4.3.2 Infants with Neonatal CLD 44

Browse All Pharmaceuticals and Healthcare Market Research Reports at: http://www.researchmoz.us/pharmaceutical-and-healthcare-market-reports-1.html

About ResearchMoz

ResearchMoz is the world’s fastest growing collection of market research reports worldwide. Our database is composed of current market studies from over 100 featured publishers worldwide. Our market research databases integrate statistics with analysis from global, regional, country and company perspectives.

Contact Us:

ResearchMoz
Mr. Nachiket Ghumare, +1-518-621-2074
USA-Canada Toll Free: 866-997-4948
sales@researchmoz.us
http://www.researchmoz.us/

 

 

Pressemitteilungen

Industry Analysis on Global Bio-based Propylene Glycol Market to Grow Rapidly at a CAGR of Approximately 8.19% during 2016 – 2020

Global Bio-based Propylene Glycol Market 2016-2020 Size and Share Published in 2016-04-28 Available for US$ 2500 at Researchmoz.us

Description

About Bio-based propylene glycol

Bio-based propylene glycol is considered as an alternative for petroleum-based propylene glycol. It is produced from plant and animal sources and is more reliable and comparatively pure than petroleum-based propylene glycol. The chemical is used in cosmetics, food, pharmaceuticals, unsaturated polyester resins, and antifreeze agents.

Technavios analysts forecast the global bio-based propylene glycol market to grow at a CAGR of 8.19% during the period 2016-2020.

Covered in this report

The report covers the present scenario and the growth prospects of the global bio-based propylene glycol market for 2016-2020. To The market for pharmaceuticals, cosmetics, and food are supposed to propel the demand for bio-based propylene glycol.

The market is divided into the following segments based on geography:

APAC

Europe

North America

ROW

Technavio’s report, Global Bio-Based Propylene Glyocol Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors

Archer-Daniels-Midland (ADM)

Ashland

BASF

Cargill

Oleon

Get a Sample Copy of the Report: http://www.researchmoz.us/enquiry.php?type=S&repid=715934

 

Other prominent vendors

Houghton Chemical

Orison

Market driver

Demand from automobile industry

For a full, detailed list, view our report

Market challenge

Competition from petroleum-based propylene glycol

For a full, detailed list, view our report

Market trend

Shift toward bio-based organic products

For a full, detailed list, view our report

Key questions answered in this report

What will the market size be in 2020 and what will the growth rate be?

What are the key market trends?

What is driving this market?

What are the challenges to market growth?

Who are the key vendors in this market space?

What are the market opportunities and threats faced by the key vendors?

What are the strengths and weaknesses of the key vendors?

Inquiry on this report: http://www.researchmoz.us/enquiry.php?type=E&repid=715934

 

Table of Content

PART 01: Executive summary

Highlights

PART 02: Scope of the report

Market overview

Research methodology

PART 03: Market research methodology

Economic indicators

PART 04: Introduction

Key market highlights

Overview

PART 05: Market landscape

Global bio-based propylene glycol market

PART 06: Market segmentation by application

Global bio-based propylene glycol market for unsaturated polyester resins

Global bio-based propylene glycol market for functional fluids and antifreeze products

Global bio-based propylene glycol market for pharmaceuticals, cosmetics, and food

Global bio-based propylene glycol market for detergents and household products

Global bio-based propylene glycol market for other applications

Browse All Chemicals Market Research Reports at: http://www.researchmoz.us/chemicals-market-reports-57.html

 

About ResearchMoz

ResearchMoz is the world’s fastest growing collection of market research reports worldwide. Our database is composed of current market studies from over 100 featured publishers worldwide. Our market research databases integrate statistics with analysis from global, regional, country and company perspectives.

Contact Us:

ResearchMoz
Mr. Nachiket Ghumare, +1-518-621-2074
USA-Canada Toll Free: 866-997-4948
sales@researchmoz.us
http://www.researchmoz.us/

Pressemitteilungen

Ontario investiert in Taro Pharmaceuticals

Mit finanziellem Support der Provinzregierung verdoppelt Taro Pharmaceuticals seine Produktionskapazitäten

Mit rund sieben Millionen kanadischen Dollar (etwa 4,6 Millionen Euro) fördert Ontario ein Projekt von Taro Pharmaceuticals, das dem Unternehmen einen Ausbau der Produktionsmöglichkeiten sowie der Forschungs- und Entwicklungsarbeit am Standort Brampton ermöglichen wird.

Die Produktionskapazität des Werks in Brampton wird dadurch um 50 Prozent gesteigert, was Taro das Potenzial gibt, sein Angebot von 20 auf 40 Produkte zu verdoppeln. Dabei entstehen 140 neue Arbeitsplätze in der Region.

Daryl LeSueur, Vice President, Head of Operations von Taro Pharmaceuticals Inc. sagt dazu: „Wir freuen uns darauf, unser Angebot hochqualitativer Produkte weiter auszubauen und dank geringerer Transport- und Supply-Chain-Kosten auch in Zukunft wettbewerbsfähig zu sein.“

Das gesamte Projekt, dessen Umfang bei 247 Millionen kan. Dollar (162 Millionen Euro) liegt, ermöglicht dem Unternehmen eine effizientere Verknüpfung von Grundlagenforschung und Herstellung von Medikamenten. Taro Pharmaceutical Industries liefert Medikamente in mehr als 25 Länder auf der ganzen Welt, wobei der Hauptmarkt auf Kanada, den USA sowie Israel liegt.

Ontario exportiert jedes Jahr pharmazeutische Produkte im Wert von fünf Milliarden kan. Dollar (3,2 Milliarden Euro). Und auch was Forschung angeht spielt die kanadische Provinz auf höchstem Niveau: Von den zehn größten Pharmaunternehmen der Welt forschen acht in Ontario.

Über Ontario, Kanada
Die Provinz Ontario ist der Wirtschaftsmotor Kanadas. Sie ist das Zentrum für Auslandsinvestitionen und Handel in Nordamerika und bietet direkten Zugang zum NAFTA-Markt, der ein Handelsvolumen von 13 Milliarden Euro (17 Bill. US-Dollar) verbucht. Weitere Pluspunkte sind multikulturelle Arbeitskräfte, klare Regulierungen, ein risikoarmes Investitionsklima, ein wettbewerbsfähiges Wirtschaftsumfeld und eine hohe Lebensqualität. Weltmarktführer aus der Automobilindustrie, Luft- und Raumfahrt, Life Sciences und Biotech, Informations- und Kommunikationstechnologien (IKT), Wasser- und Abwassertechnologien, Finanzbranche und Bergbau haben sich hier niedergelassen und Milliarden in den Standort Ontario investiert. Namhafte Firmen in Ontario sind beispielsweise Honda, Magna, Sodexo, Alcatel-Lucent, AXA, Bombardier, DuPont, MDS, Sanofi Pasteur, GlaxoSmithKline, Trojan, IBM und Dell.

Die Bevölkerung in der Provinz zählt fast 13 Millionen und ist damit die größte in Kanada. Ontario generiert rund 38 Prozent von Kanadas Bruttoinlandsprodukt. Das BIP ist größer als beispielsweise das von Belgien oder der Schweiz. Der Wert der Importe und Exporte lag 2012 bei mehr als 315 Milliarden Euro (424 Mrd. kan. Dollar). In Ontario ansässige Firmen exportierten im gleichen Jahr mehr als 90 Milliarden Euro (126 Mrd. kan. Dollar) an Waren in die USA.

Ministry of Economic Development, Trade and Employment
Patricia Pytel
5th Floor, Hearst Block, 900 Bay Street
M7A 2E1 Toronto Ontario Canada
+1 (416) 314-8704
patricia.pytel@ontario.ca
http://www.presseforum.cc/ontario

Communication Consultants GmbH Engel & Heinz
Christine Fröhler Markus Engel
Jurastraße 8
70565 Stuttgart
+49 (711) 97893.37
ontario@postamt.cc
http://www.presseforum.cc/ontario